176 related articles for article (PubMed ID: 37041057)
1. Effects of oral immunonutritional supplement on 3-year disease-free survival in gastric cancer patients with pathological stage III after total gastrectomy (CRUCIAL): study protocol of a multicentre, randomised clinical trial.
Zhou D; Liu Y; Zhang L; Lu M; Gao X; Li G; Xiang X; Xu H; Li G; Sun Z; Wei W; Yi K; Zuo J; Wu Y; Qian J; Zhou J; Duan K; Wu Y; Tian Z; Jiang C; Wang X
BMJ Open; 2023 Apr; 13(4):e067990. PubMed ID: 37041057
[TBL] [Abstract][Full Text] [Related]
2. Prospective multicentre randomised clinical trial comparing survival rates, quality of life and nutritional status between advanced gastric cancer patients with different follow-up intensities: study protocol for the STOFOLUP trial.
Eom BW; Koo DH; An JY; Lee HH; Kim HI; Hur H; Yoo MW; Ryu MH; Lee HJ; Kim SM; Park JH; Min JS; Seo KW; Jeong SH; Jeong O; Kwon OK; Ryu SW; Yoo CH; Bae JM; Ryu KW
BMJ Open; 2021 Dec; 11(12):e056187. PubMed ID: 34880028
[TBL] [Abstract][Full Text] [Related]
3. Comparison of short-term outcomes and quality of life in totally laparoscopic distal gastrectomy and totally robotic distal gastrectomy for clinical stage I-III gastric cancer: study protocol for a multi-institutional randomised clinical trial.
Cui H; Cao B; Liu G; Xi H; Chen Z; Liang W; Zhang K; Cui J; Xie T; Deng H; Tang Y; Chen L; Wei B
BMJ Open; 2021 May; 11(5):e043535. PubMed ID: 34035091
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol.
Cheng X; Wu D; Xu N; Chen L; Yan Z; Chen P; Zhou L; Yu J; Cui J; Li W; Wang C; Feng W; Wei Y; Yu P; Du Y; Ying J; Xu Z; Yang L; Zhang Y
BMC Cancer; 2021 Jan; 21(1):56. PubMed ID: 33435909
[TBL] [Abstract][Full Text] [Related]
5. Minimally invasivE versus open total GAstrectomy (MEGA): study protocol for a multicentre randomised controlled trial (DRKS00025765).
Nickel F; Studier-Fischer A; Hausmann D; Klotz R; Vogel-Adigozalov SL; Tenckhoff S; Klose C; Feisst M; Zimmermann S; Babic B; Berlt F; Bruns C; Gockel I; Graf S; Grimminger P; Gutschow CA; Hoeppner J; Ludwig K; Mirow L; Mönig S; Reim D; Seyfried F; Stange D; Billeter A; Nienhüser H; Probst P; Schmidt T; Müller-Stich BP
BMJ Open; 2022 Oct; 12(10):e064286. PubMed ID: 36316075
[TBL] [Abstract][Full Text] [Related]
6. Post-discharge oral nutritional supplements with dietary advice in patients at nutritional risk after surgery for gastric cancer: A randomized clinical trial.
Meng Q; Tan S; Jiang Y; Han J; Xi Q; Zhuang Q; Wu G
Clin Nutr; 2021 Jan; 40(1):40-46. PubMed ID: 32563598
[TBL] [Abstract][Full Text] [Related]
7. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II).
Koemans WJ; van der Kaaij RT; Boot H; Buffart T; Veenhof AAFA; Hartemink KJ; Grootscholten C; Snaebjornsson P; Retel VP; van Tinteren H; Vanhoutvin S; van der Noort V; Houwink A; Hahn C; Huitema ADR; Lahaye M; Los M; van den Barselaar P; Imhof O; Aalbers A; van Dam GM; van Etten B; Wijnhoven BPL; Luyer MDP; Boerma D; van Sandick JW
BMC Cancer; 2019 May; 19(1):420. PubMed ID: 31060544
[TBL] [Abstract][Full Text] [Related]
8. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
[TBL] [Abstract][Full Text] [Related]
9. Impact of oral nutritional supplements in post-discharge patients at nutritional risk following colorectal cancer surgery: A randomised clinical trial.
Tan S; Meng Q; Jiang Y; Zhuang Q; Xi Q; Xu J; Zhao J; Sui X; Wu G
Clin Nutr; 2021 Jan; 40(1):47-53. PubMed ID: 32563599
[TBL] [Abstract][Full Text] [Related]
10. Treatment using oxaliplatin and S-1 adjuvant chemotherapy for pathological stage III gastric cancer: a multicenter phase II study (TOSA trial) protocol.
Namikawa T; Maeda H; Kitagawa H; Oba K; Tsuji A; Yoshikawa T; Kobayashi M; Hanazaki K
BMC Cancer; 2018 Feb; 18(1):186. PubMed ID: 29439671
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Effect of different oesophagojejunostomy methods on the quality of life of gastric cancer patients after totally laparoscopic total gastrectomy with self-pulling and latter transected technique: study protocol for a randomised trial.
Wang J; Tseng Y; Hong J; Hua LC; Wang YP; Hao HK
BMJ Open; 2022 Apr; 12(4):e058844. PubMed ID: 35428644
[TBL] [Abstract][Full Text] [Related]
13. Multimodal prehabilitation to improve the clinical outcomes of frail elderly patients with gastric cancer: a study protocol for a multicentre randomised controlled trial (GISSG
Sun Y; Tian Y; Cao S; Li L; Yu W; Ding Y; Wang X; Kong Y; Wang X; Wang H; Hui X; Qu J; Wang H; Duan Q; Yang D; Zhang H; Zhou S; Liu X; Li Z; Meng C; Kehlet H; Zhou Y
BMJ Open; 2023 Oct; 13(10):e071714. PubMed ID: 37816552
[TBL] [Abstract][Full Text] [Related]
14. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial.
Fujitani K; Yang HK; Mizusawa J; Kim YW; Terashima M; Han SU; Iwasaki Y; Hyung WJ; Takagane A; Park DJ; Yoshikawa T; Hahn S; Nakamura K; Park CH; Kurokawa Y; Bang YJ; Park BJ; Sasako M; Tsujinaka T;
Lancet Oncol; 2016 Mar; 17(3):309-318. PubMed ID: 26822397
[TBL] [Abstract][Full Text] [Related]
15. The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II.
Leers JM; Knepper L; van der Veen A; Schröder W; Fuchs H; Schiller P; Hellmich M; Zettelmeyer U; Brosens LAA; Quaas A; Ruurda JP; van Hillegersberg R; Bruns CJ
BMC Cancer; 2020 Aug; 20(1):781. PubMed ID: 32819399
[TBL] [Abstract][Full Text] [Related]
16. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
[TBL] [Abstract][Full Text] [Related]
17. Postoperative complications and nutritional status between uncut Roux-en-Y anastomosis and Billroth II anastomosis after D2 distal gastrectomy: a study protocol for a multicenter randomized controlled trial.
Chen S; Chen DW; Chen XJ; Lin YJ; Xiang J; Peng JS
Trials; 2019 Jul; 20(1):428. PubMed ID: 31300019
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.
Bang YJ; Kim YW; Yang HK; Chung HC; Park YK; Lee KH; Lee KW; Kim YH; Noh SI; Cho JY; Mok YJ; Kim YH; Ji J; Yeh TS; Button P; Sirzén F; Noh SH;
Lancet; 2012 Jan; 379(9813):315-21. PubMed ID: 22226517
[TBL] [Abstract][Full Text] [Related]
19. Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage IA or IB gastric cancer (JCOG0912): a multicentre, non-inferiority, phase 3 randomised controlled trial.
Katai H; Mizusawa J; Katayama H; Morita S; Yamada T; Bando E; Ito S; Takagi M; Takagane A; Teshima S; Koeda K; Nunobe S; Yoshikawa T; Terashima M; Sasako M
Lancet Gastroenterol Hepatol; 2020 Feb; 5(2):142-151. PubMed ID: 31757656
[TBL] [Abstract][Full Text] [Related]
20. Thymosin alpha 1 in the prevention of infected pancreatic necrosis following acute necrotising pancreatitis (TRACE trial): protocol of a multicentre, randomised, double-blind, placebo-controlled, parallel-group trial.
Zhou J; Mao W; Ke L; Chen T; He W; Pan X; Chen M; He C; Gu W; Wu J; Song J; Ni H; Tu J; Sun J; Zhang G; Chen W; Xue B; Zhao X; Shao M; Liu Y; Tong Z; Li W;
BMJ Open; 2020 Sep; 10(9):e037231. PubMed ID: 32994239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
